Furthermore, through the ectopic expression of LMP1 on patient-derived tumor B cells to prime T cells, autologous cytotoxic CD4+ T cells can be expanded to target a wide range of endogenous tumor antigens, including TAAs and neoantigens. Here, CD4 is linked to neoplasm.